Who is sponsoring NCT03118648?

NCT03118648 is sponsored by University Hospital, Bordeaux.

What drugs are being tested in NCT03118648?

Interventions in NCT03118648: Scale Action Research Arm Test (ARAT).

What condition does NCT03118648 study?

NCT03118648 studies Stroke Rehabilitation.

Is NCT03118648 still recruiting?

NCT03118648 is currently status unknown. Last updated 22 June 2017.

Last reviewed 2017-06-22 · How we verify

NCT03118648: Post AVC-AVQ

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Recovery of Upper Limb Paresis at Discharge After Stroke and Its Level of Use in Activities of Daily Living 3 to 6 Months Later (Post AVC-AVQ)

Status unknown Last updated 22 June 2017

What this trial tests

trial testing Scale Action Research Arm Test (ARAT) in Stroke Rehabilitation in 192 participants. Status unknown.

Timeline

1 July 2017

Primary endpoint
1 June 2020

1 June 2020

Quick facts

Lead sponsor	University Hospital, Bordeaux
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	192
Start date	1 July 2017
Primary completion	1 June 2020
Estimated completion	1 June 2020
Sites	1 location across France

Drugs / interventions tested

Scale Action Research Arm Test (ARAT)

Conditions studied

Stroke Rehabilitation — all drugs for Stroke Rehabilitation →

Sponsor

University Hospital, Bordeaux

Who can join

18 and older, any sex, with Stroke Rehabilitation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to reduct spontaneous use an activities of daily living of the paretic upper limb after stroke i six months after patient discharge from rehabilitation center. The level of functional recovery at rehabilitation discharge could better guide rehabilitation strategies to enhance independence and participation in daily life. This study aims to determine, in patients after stroke, the optimal affected upper limb recovery threshold at rehabilitation discharge to predict spontaneous level of use of affected upper limb in activities of daily living, six month later. This study is a multicentric prognostic prospective cohort study. The main prognostic variable will be the Action Arm Test (ARAT, Lyle, 1981) score at rehabilitation discharge and the predicted variable will be the Motor Activity Log - 28 (Taub et al. 1993) score at 6 months post discharge.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke Rehabilitation

Currently open trials in the same condition.

NCT07228754 — How Realistic Are Caregivers' Expectations in Patients With Subacute Stroke? · recruiting
NCT06998485 — Substrates for Post-Stroke Arm Rehabilitation · NA · recruiting
NCT07229053 — Hospitalisation Duration in Stroke Patients · recruiting
NCT06965894 — Lower Extremity Pressure Splints in HP · NA · recruiting
NCT06898073 — Dual-task Training During Curved Walking in Stroke Patients · NA · recruiting

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

NCT07506928 — NEURO - Prognostication Using Late Somatosensory Evoked - Potentials · NA · not yet recruiting
NCT07524036 — Impact of a Nursing Educational Consultation on the Patient's Adherence to Their Post-stroke Care Plan. · NA · not yet recruiting
NCT07527494 — Digital MEDIcal TWIN for the Prediction of Arrhythmic Sudden Cardiac Death After a Myocardial Infarction · NA · not yet recruiting
NCT07527442 — Efficacy and Safety of Circumcision Alone on Risk of Febrile Urinary Tract Infections in Boys With Posterior Urethral Va · Phase 2 · not yet recruiting
NCT07478523 — FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03118648 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Bordeaux
Last refreshed: 22 June 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03118648.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing